Latest Regulation News

Viridis Mining and Minerals has announced a substantial upgrade to its Colossus Ionic Adsorption Clay Rare Earth Element Project, reporting a 140% increase in its JORC-compliant Mineral Resource Estimate. This positions Colossus as the largest and highest-grade IAC rare earth resource globally, with significant implications for the rare earth sector.

Delta Lithium reports strong drilling results and successful metallurgical test work at its Yinnetharra Lithium Project, underpinning confidence in resource expansion and future development plans.

Terramin Australia’s attempt to secure a mining lease for its Bird in Hand Gold Project has been rejected by the South Australian Supreme Court, which upheld the government’s refusal and reservation of the land. The company is set to appeal, keeping the project’s future uncertain.

Xanadu Mines has lodged a comprehensive NI 43-101 technical report for its Kharmagtai Copper-Gold Project, revealing key differences in production and economic outcomes compared to earlier ASX disclosures due to regulatory standards.

Magnetic Resources has significantly increased the gold resource estimate at its Lady Julie Gold Project to 1.75 million ounces, advancing plans for concurrent underground mining and an expanded processing plant.

Arrow Minerals is fast-tracking a Scoping Study for a Direct Shipping Ore operation at its Niagara Bauxite Project in Guinea, leveraging strong drilling results and strategic infrastructure access to capitalise on record bauxite prices.

Saturn Metals made significant progress on its Apollo Hill Gold Project during the December 2024 quarter, reporting strong drilling results and advancing its Pre-Feasibility Study despite a tragic on-site fatality. The company ended the quarter with a solid cash position of $9.5 million.

Element 25 has obtained key regulatory approval from WA's DEMIRS for its Butcherbird Expansion Project, paving the way for a twelve-year production run at 1.1 million tonnes per annum of manganese concentrate. The final hurdle remains the Works Approval, expected imminently.

EBR Systems has announced a rescheduling of the FDA Pre-Approval Inspection for its wireless cardiac pacing device to January 14, 2025, while maintaining its regulatory approval timeline for Q1 2025 and a commercial launch later in the year.